<!DOCTYPE html>
<html lang="en">

  <head>

    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="description" content="">
    <meta name="author" content="">

    <title>Dr Michael Taynnan Barros - Communicating Unconventional Medical Devices and Systems</title>

    <!-- Bootstrap core CSS -->
    <link href="vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">

    <!-- Custom fonts for this template -->
    <link href="vendor/fontawesome-free/css/all.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Varela+Round" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Nunito:200,200i,300,300i,400,400i,600,600i,700,700i,800,800i,900,900i" rel="stylesheet">

    <!-- Custom styles for this template -->
    <link href="css/creative.css" rel="stylesheet">
    <link href="css/stylish-portfolio.css" rel="stylesheet">
    <link href="css/grayscale.min.css" rel="stylesheet">
    
    <link href="vendor/magnific-popup/magnific-popup.css" rel="stylesheet">

  </head>

  <body id="page-top">

    <!-- Navigation -->
    <nav class="navbar navbar-expand-lg navbar-white fixed-top" id="mainNav">
      <img src="img/essex2.png" alt="" width="150" height="125" class="img-fluid mb-3 mb-lg-0">
      <div class="container"><a class="navbar-brand js-scroll-trigger" href="#page-top">Dr Michael Taynnan Barros</a>
        <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation">
          Menu
          <i class="fas fa-bars"></i>
        </button>
        <div class="collapse navbar-collapse" id="navbarResponsive">
          <ul class="navbar-nav ml-auto">
             <li class="nav-item">
              <a class="nav-link js-scroll-trigger" href="index.html">About</a>
            </li>
            <li class="nav-item">
              <a class="nav-link js-scroll-trigger" href="research.html">Research</a>
            </li>
            <li class="nav-item">
                <a class="nav-link js-scroll-trigger" href="https://www.essex.ac.uk/departments/computer-science-and-electronic-engineering/research/communications-and-networks/unconventional-communications-and-computing-laboratory">UC2 lab</a>
              </li>
            <li class="nav-item">
              <a class="nav-link js-scroll-trigger" href="pub.html">Publication</a>
            </li>
            <li class="nav-item">
                <a class="nav-link js-scroll-trigger" href="team.html">People</a>
              </li>
            <li class="nav-item">
              <a class="nav-link js-scroll-trigger" href="service.html">Service</a>
            </li>
          </ul>
        </div>
      </div>
    </nav>

    <!-- Header -->
    <!-- About Section -->

    <!-- Replicate the above Div block to add more title and company details --> 
      <section id="projects" class="projects-section bg-dark">
      <div class="container">
        
        <h1 class="Title text-white-50">Research</h1>

         <br>
         <br>
<!-- 
        <h3 class="text-white text-center text-justify"> Communicating unconventional medical devices and systems: bridging molecules to the Internet.</h3> 
        <h7 class="text-white-50 text-justify">We combine models of wireless and molecular communications with biological intracellular-tissue models in order to provide precise and targeted sensing or treatment of diseases. We use unconventional medical devices that range from silicon/metamaterilas to synthetic biological devices, and their combinations.</h7>

        <br>
        <br>
        <br> -->

        <section class="about-section text-center" id="about">
            <div class="container">
                <div class="row">
                    <div class="col-lg-11 mx-auto width=250 height=150" >
                        <h2 class="text-white mb-4">Enabling eco-friendly biological cybernetics for biotechnology: Advancing from biocomputing to biological AI.</h2>
                        <p class="text-white-50">
                          We advance carbon-neutral, batteryless, and beyond-silicon communication and computing technologies for bioengineering, precision medicine, and pharmacology. Utilizing artificial intelligence, we design, develop and control technologies that enable the seamless integration of biohybrid, synthetic and natural biological systems.                        </p>
                    </div>
                </div>
                <!-- <img class="img-fluid" src="img/research.gif" width="820" height="800" alt="" /> -->
                <img class="img-fluid" src="img/funders2.png" alt="" />
                <br><br><br>
                
                <h2 class="text-white mb-4"> Funding History</h2>
                <p class="sectionContent"> 
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, UKRI BBSRC IAA Engagement Award – Optimisation of exosome-based therapies from 3D BioPrinted stem cell structures. (2023-2024)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">Co-I</span>, UKRI BBSRC Pioneers Award – ROS signaling in plants: Are we missing a fundamental pathway? (2024-2026)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, InnovateUK Knowledge Transfer Partnership, 3D Bioprinting technology for new market solutions in the UK. Participants: University of Essex and iMakr Group. (2022-2024) </li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, Marie Skłodowska-Curie Individual Fellowship (EU-H2020-MSCA-IF), STOICISM - Stochastic Communication Inside Cortical Microcolumns. (2019-2022)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, WIT President PhD Funding, Internet of Nano Things for the Next Generation Theranostics of Brain Glioblastomas.  (2019-2023)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">Co-I</span>, EU-H2020-FET. GLADIATOR:  Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces.  (2018-2022)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, Enterprise Ireland Commercialisation Fund, CDaaS – Clinical Data as a Service. (2018-2019)</li><br>
                  <li class="text-white-50" style="margin-left: 40px"><span style="color: whitesmoke">PI</span>, Irish Research Council, Government of Ireland Postdoc Fellowship, Application of Control Theory in Molecular Communication for the Treatment of Alzheimer’s Disease  (2016-2018)</li><br>
                </p>
            </div>
        </section>

        <br>
        <br>
        <br>

        <!-- Project One Row -->
        <div class="row justify-content-center no-gutters mb-5 mb-lg-0">
          <div class="col-lg-6">
            <img class="img-fluid" src="img/r12.png" alt="">
          </div>
          <div class="col-lg-6">
            <div class="bg-black text-center h-100 project">
              <div class="d-flex h-100">
                <div class="project-text w-100 my-auto text-center text-lg-left">
                  <h4 class="text-white text-center">Biocomputing with living systems: lowering energy costs in computing</h4>
                  <p class="mb-0 text-white-50 text-justify"> Controlling tissue communication allows us to explore novel activity patterns, leading to new tissue behaviors. From this, we propose biocomputing, where cell communication can be optimized to perform Boolean logic gates. We have successfully achieved logic gate functions in astrocytes, neurons, and bacteria using various cell types. Our research includes both in-silico and in-vitro models demonstrating this technology’s feasibility. We have developed control and optimization models, ranging from mathematical derivations in control theory to machine learning-based optimizations.Our future plans involve extensive exploration to advance biological computing tasks possible through this approach and identifying the biological parameters necessary for fully optimized biocomputing systems. We will also expand our analysis to in-vitro models to explore the potential sensing and treatment technologies emerging from biocomputing systems, aiming to provide more efficient and biocompatible solutions than current biomedical devices..</p>
                  <hr class="d-none d-lg-block mb-0 mr-0">
                </div>
              </div>
            </div>
          </div>
        </div>

        <!-- Project Two Row -->
        <div class="row justify-content-center no-gutters">
          <div class="col-lg-6">
            <img class="img-fluid" src="biop.png" alt="">
          </div>
          <div class="col-lg-6 order-lg-first">
            <div class="bg-black text-center h-100 project">
              <div class="d-flex h-100">
                <div class="project-text w-100 my-auto text-center text-lg-right">
                  <h4 class="text-white text-center">Data-Driven 3D Bioprinting for Smart, Adaptable, and Remote-Controlled Biomaterials</h4>
                  <p class="mb-0 text-white-50 text-justify">
                    Data-driven 3D bioprinting is revolutionizing the development of smart, adaptable, and remote-controlled biomaterials. By leveraging advanced AI and machine learning algorithms, we design and fabricate bioprinted biomaterials tailored to individual patient needs. These biomaterials can dynamically adapt to changing biological conditions and be controlled remotely for precise therapeutic interventions. Our approach integrates environmental data from where the biomaterials will operate to devise strategies optimizing their functionality and performance. This enables the creation of personalized medical solutions that enhance patient outcomes. Our research focuses on developing biocompatible materials and ensuring their long-term stability and integration. Our goal is to push the boundaries of medical biomaterials, making them more efficient, versatile, and accessible, thereby contributing to the future of personalized medicine.                  </p>
                  <hr class="d-none d-lg-block mb-0 ml-0">
                </div>
              </div>
            </div>
          </div>
        </div>
        
        
        <div class="row justify-content-center no-gutters mb-5 mb-lg-0">
          <div class="col-lg-6">
            <img class="img-fluid" src="img/r21.gif" alt="">
          </div>
          <div class="col-lg-6">
            <div class="bg-black text-center h-100 project">
              <div class="d-flex h-100">
                <div class="project-text w-100 my-auto text-center text-lg-left">
                  <h4 class="text-white text-center"> AI in Biology and Medicine: Accelerating the Modeling and Interfacing of Biological Systems</h4>
                  <p class="mb-0 text-white-50 text-justify"> Molecular propagation, interaction, and information encoding are fundamental to the development, function, and evolution of biological and medical systems, manifesting in diverse ways. We leverage AI to enhance our understanding of these systems, addressing the challenges and limitations of experimental biology. Our goal is to improve disease detection and treatment by training AI models with limited data to inform biologists and medical professionals. We successfully develop digital twins of neurons, astrocytes, smooth muscle cells, epithelial cells, and bacteria, creating 3D+T digital reconstructions of tissues and organs. Our in-silico models are closely aligned with in-vitro experimental data to produce validated digital twin solutions. Our research spans several critical areas, including genetic information processing, gene network discovery, molecular biophysical modeling, experimental microscopic imaging analysis, and dynamical biomarker discovery. We aim to push the boundaries of AI in biology and medicine, contributing to a future where technology and healthcare converge to provide better, more accessible, and individualized medical solutions worldwide.
                    <!-- Molecular communciations is a recent interdisciplinary research area that integrates concepts from telecommunications and computer networks for the dual goal of 1) designing communication using molecules for synthetically engineered cells or unconventional implantable medical devices and 2) further analyse biological communications for deeper understanding of tissues and organs functioning. We have sucessfully designed communication system models using in-silico and in-vitro models of different types of biological systems including,  -->
                  <!-- This research is supported by European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 839553.  -->
                  </p>
                  <hr class="d-none d-lg-block mb-0 ml-0">
                </div>
              </div>
            </div>
          </div>
        </div>

        <!-- Project Two Row -->
        <div class="row justify-content-center no-gutters">
          <div class="col-lg-6">
            <img class="img-fluid" src="img/r32.png" alt="">
          </div>
          <div class="col-lg-6 order-lg-first">
            <div class="bg-black text-center h-100 project">
              <div class="d-flex h-100">
                <div class="project-text w-100 my-auto text-center text-lg-right">
                  <h4 class="text-white text-center">Wireless Communications for Biomedical Distributed Interfaces</h4>
                  <p class="mb-0 text-white-50 text-justify">
                    The large-scale and long-term implantation of unconventional medical systems relies on the precise distribution of devices or externally controlled cells for specific sensing or actuation within the body. This is achievable only if these systems communicate with each other and external entities, a technology we call in-vivo networking. This concept is foundational for developing the futuristic vision of the Internet of Bio-Nano Things. We have created networking protocols for ultrasound-based communications between external and implantable devices. Our work involves manipulating ultrasound signals for communication and powering batteryless implantable systems for neural interfaces, which serve as AI-powered sensing mechanisms for biological neural networks. We are now expanding to multiple communication channels using ultrasound, optical, and RF-mmWave signals. Additionally, we are validating our models with 3D ex-vivo platforms, testing how wireless signals can be modified to overcome signal losses and impedance mismatches, aiming for high-bandwidth interfaces.
                  </p>
                  <hr class="d-none d-lg-block mb-0 ml-0">
                </div>
              </div>
            </div>
          </div>
        </div>

      </div>
      
      
      
    </section>

    <!-- Footer -->
    <footer class="bg-black small text-center text-white-50">
      <div class="container"> Copyright &copy; Dr. Michael Taynnan Barros 2024 </div>
    </footer>   

    <!-- Bootstrap core JavaScript -->
    <script src="vendor/jquery/jquery.min.js"></script>
    <script src="vendor/bootstrap/js/bootstrap.bundle.min.js"></script>

    <!-- Plugin JavaScript -->
    <script src="vendor/jquery-easing/jquery.easing.min.js"></script>

    <!-- Custom scripts for this template -->
    <script src="js/grayscale.min.js"></script>

  </body>

</html>
